Manufacturer of Controlled Substances; Notice of Application, 3543-3545 [E6-720]
Download as PDF
<![CDATA[
3543
Federal Register / Vol. 71, No. 14 / Monday, January 23, 2006 / Notices
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Prescription Monitoring Program
Questionnaire.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number: None. Office of Diversion
Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State. Other: None.
This questionnaire permits the Drug
Enforcement Administration to compile
and evaluate information regarding the
design, implementation and operation
of state prescription monitoring
programs. Such information allows DEA
to assist states in the development of
new programs designed to enhance the
ability of both DEA and state authorities
to prevent, detect, and investigate the
diversion and abuse of controlled
substances.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 26 persons
complete the Prescription Monitoring
Program Questionnaire on paper and 25
persons complete the form
electronically, at 5 hours per form, for
an annual burden of 255 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
255 annual burden hours associated
with this collection.
If additional information is required
contact: Brenda E. Dyer, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: January 17, 2006.
Brenda E. Dyer,
Department Clearance Officer, Department of
Justice.
[FR Doc. E6–681 Filed 1–20–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 17, 2005,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78664, made application by renewal to
the Drug Enforcement Administration
(DEA) for registration as a bulk
manufacturer of the basic classes of
controlled substances listed in Schedule
I and II:
erjones on PROD1PC61 with NOTICES
Drug
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
Gamma Hydroxybutyric acid (2010) ............................................................................................................................................................
Methaqualone (2565) ..................................................................................................................................................................................
Alpha-Ethyltryptamine (7249) ......................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine (7401) ..................................................................................................................................
N-Hydroxy-3,4-methylendioxyamphetamine (7402) ....................................................................................................................................
3,4-Methylendioxy-N-ethylamphetamine (7404) ..........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Bufotenine (7433) ........................................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
Acetyldihydrocodeine (9051) .......................................................................................................................................................................
Benzylmorphine (9052) ...............................................................................................................................................................................
Codeine-N-oxide (9053) ..............................................................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Hydromorphinol (9301) ................................................................................................................................................................................
Methyldihydromorphine (9304) ....................................................................................................................................................................
Morphine-N-oxide (9307) .............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Pholcodine (9314) .......................................................................................................................................................................................
VerDate Aug<31>2005
13:01 Jan 20, 2006
Jkt 208001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
E:\FR\FM\23JAN1.SGM
23JAN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
3544
Federal Register / Vol. 71, No. 14 / Monday, January 23, 2006 / Notices
Drug
Schedule
erjones on PROD1PC61 with NOTICES
Acetylmethadol (9601) .................................................................................................................................................................................
Allylprodine (9602) .......................................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol (9603) ......................................................................................................................
Alphameprodine (9604) ...............................................................................................................................................................................
Alphamethadol (9605) .................................................................................................................................................................................
Betacetylmethadol (9607) ............................................................................................................................................................................
Betameprodine (9608) .................................................................................................................................................................................
Betamethadol (9609) ...................................................................................................................................................................................
Betaprodine (9611) ......................................................................................................................................................................................
Hydroxypethidine (9627) .............................................................................................................................................................................
Noracymethadol (9633) ...............................................................................................................................................................................
Norlevorphanol (9634) .................................................................................................................................................................................
Normethadone (9635) .................................................................................................................................................................................
Trimeperidine (9646) ...................................................................................................................................................................................
Phenomorphan (9647) .................................................................................................................................................................................
Para-Fluorofentanyl (9812) ..........................................................................................................................................................................
3-Methylfentanyl (9813) ...............................................................................................................................................................................
Alpha-Methylfentanyl (9814) ........................................................................................................................................................................
Acetyl-alpha-methylfentanyl (9815) .............................................................................................................................................................
Beta-hydroxyfentanyl (9830) .......................................................................................................................................................................
Beta-hydroxy-3-methylfentanyl (9831) ........................................................................................................................................................
Alpha-Methylthiofentanyl (9832) ..................................................................................................................................................................
3-Methylthiofentanyl (9833) .........................................................................................................................................................................
Thiofentanyl (9835) ......................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Phenmetrazine (1631) .................................................................................................................................................................................
Methylphenidate (1724) ...............................................................................................................................................................................
Ambobarbital (2125) ....................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Glutethimide (2550) .....................................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................
Alphaprodine (9010) ....................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Diphenoxylate (9170) ..................................................................................................................................................................................
Benzoylecgonine (9180) ..............................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Isomethadone (9226) ..................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Methadone intermediate (9254) ..................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
Racemethorphan (9732) ..............................................................................................................................................................................
Alfentanil (9737) ..........................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to their
customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
VerDate Aug<31>2005
13:01 Jan 20, 2006
Jkt 208001
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
E:\FR\FM\23JAN1.SGM
23JAN1
3545
Federal Register / Vol. 71, No. 14 / Monday, January 23, 2006 / Notices
Alexandria, Virginia 22301; and must be
filed no later than (60 days from
publication).
DEPARTMENT OF JUSTICE
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–720 Filed 1–20–06; 8:45 am]
Importer of Controlled Substances;
Notice of Application
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
erjones on PROD1PC61 with NOTICES
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 31, 2005,
Clariant LSM (Missouri), Inc., 2460 W.
Bennett Street (or P.O. Box 1246, Zip:
65801), Springfield, Missouri 65807–
1229, made application by letter to the
Drug Enforcement Administration
(DEA) for registration as a bulk
manufacturer of Phenylacetone (8501),
and Methadone Intermediate (9254), a
basic class of controlled substances
listed in Schedule II.
The company plans to manufacture in
bulk, for sale to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than March 24, 2006.
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–719 Filed 1–20–06; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
13:01 Jan 20, 2006
Jkt 208001
Drug Enforcement Administration
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on August
10, 2005, Clinical Trial Services (US),
2661 Audubon Road, Audubon,
Pennsylvania 19403, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Fentanyl (9801) and
Oxycodone (9143), basic classes of
controlled substance listed in Schedule
II.
The company plans to import small
quantities of the listed controlled
substance in dosage form to conduct
clinical trials.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than February 22, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–717 Filed 1–20–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on July 27,
2005, Cody Laboratories Inc., 601
Yellowstone Avenue, Cody, Wyoming
82414–9321, made application to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in Schedule II:
Drug
Raw Opium (9600) .......................
Poppy Straw (9650) ......................
Concentrate of Poppy Straw
(9670).
Schedule
II
II
II
The company plans to import narcotic
raw materials for manufacturing and
further distribution to its customers.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 71, Number 14 (Monday, January 23, 2006)]
[Notices]
[Pages 3543-3545]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-720]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 17, 2005, Cerilliant
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed in Schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)................................. I
Methcathinone (1237)............................. I
N-Ethylamphetamine (1475)........................ I
N,N-Dimethylamphetamine (1480)................... I
Aminorex (1585).................................. I
4-Methylaminorex (cis isomer) (1590)............. I
Gamma Hydroxybutyric acid (2010)................. I
Methaqualone (2565).............................. I
Alpha-Ethyltryptamine (7249)..................... I
Lysergic acid diethylamide (7315)................ I
Marihuana (7360)................................. I
Tetrahydrocannabinols (7370)..................... I
Mescaline (7381)................................. I
3,4,5-Trimethoxyamphetamine (7390)............... I
4-Bromo-2,5-dimethoxyamphetamine (7391).......... I
4-Bromo-2,5-dimethoxyphenethylamine (7392)....... I
4-Methyl-2,5-dimethoxyamphetamine (7395)......... I
2,5-Dimethoxyamphetamine (7396).................. I
2,5-Dimethoxy-4-ethylamphetamine (7399).......... I
3,4-Methylenedioxyamphetamine (7400)............. I
5-Methoxy-3,4-methylenedioxyamphetamine (7401)... I
N-Hydroxy-3,4-methylendioxyamphetamine (7402).... I
3,4-Methylendioxy-N-ethylamphetamine (7404)...... I
3,4-Methylenedioxymethamphetamine (7405)......... I
4-Methoxyamphetamine (7411)...................... I
Bufotenine (7433)................................ I
Diethyltryptamine (7434)......................... I
Dimethyltryptamine (7435)........................ I
Psilocybin (7437)................................ I
Psilocyn (7438).................................. I
Acetyldihydrocodeine (9051)...................... I
Benzylmorphine (9052)............................ I
Codeine-N-oxide (9053)........................... I
Dihydromorphine (9145)........................... I
Heroin (9200).................................... I
Hydromorphinol (9301)............................ I
Methyldihydromorphine (9304)..................... I
Morphine-N-oxide (9307).......................... I
Normorphine (9313)............................... I
Pholcodine (9314)................................ I
[[Page 3544]]
Acetylmethadol (9601)............................ I
Allylprodine (9602).............................. I
Alphacetylmethadol except levo-alphacetylmethadol I
(9603).
Alphameprodine (9604)............................ I
Alphamethadol (9605)............................. I
Betacetylmethadol (9607)......................... I
Betameprodine (9608)............................. I
Betamethadol (9609).............................. I
Betaprodine (9611)............................... I
Hydroxypethidine (9627).......................... I
Noracymethadol (9633)............................ I
Norlevorphanol (9634)............................ I
Normethadone (9635).............................. I
Trimeperidine (9646)............................. I
Phenomorphan (9647).............................. I
Para-Fluorofentanyl (9812)....................... I
3-Methylfentanyl (9813).......................... I
Alpha-Methylfentanyl (9814)...................... I
Acetyl-alpha-methylfentanyl (9815)............... I
Beta-hydroxyfentanyl (9830)...................... I
Beta-hydroxy-3-methylfentanyl (9831)............. I
Alpha-Methylthiofentanyl (9832).................. I
3-Methylthiofentanyl (9833)...................... I
Thiofentanyl (9835).............................. I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Phenmetrazine (1631)............................. II
Methylphenidate (1724)........................... II
Ambobarbital (2125).............................. II
Pentobarbital (2270)............................. II
Secobarbital (2315).............................. II
Glutethimide (2550).............................. II
Nabilone (7379).................................. II
1-Phenylcyclohexylamine (7460)................... II
Phencyclidine (7471)............................. II
1-Piperidinocyclohexanecarbonitrile (8603)....... II
Alphaprodine (9010).............................. II
Cocaine (9041)................................... II
Codeine (9050)................................... II
Dihydrocodeine (9120)............................ II
Oxycodone (9143)................................. II
Hydromorphone (9150)............................. II
Diphenoxylate (9170)............................. II
Benzoylecgonine (9180)........................... II
Ethylmorphine (9190)............................. II
Hydrocodone (9193)............................... II
Levomethorphan (9210)............................ II
Levorphanol (9220)............................... II
Isomethadone (9226).............................. II
Meperidine (9230)................................ II
Methadone (9250)................................. II
Methadone intermediate (9254).................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300).................................. II
Thebaine (9333).................................. II
Levo-alphacetylmethadol (9648)................... II
Oxymorphone (9652)............................... II
Noroxymorphone (9668)............................ II
Racemethorphan (9732)............................ II
Alfentanil (9737)................................ II
Sufentanil (9740)................................ II
Fentanyl (9801).................................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances to make reference standards which will be
distributed to their customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway,
[[Page 3545]]
Alexandria, Virginia 22301; and must be filed no later than (60 days
from publication).
Dated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-720 Filed 1-20-06; 8:45 am]
BILLING CODE 4410-09-P
